Level A1 – BeginnerCEFR A1
2 min
70 words
- Researchers tested a new antibody treatment in patients.
- It targets the blood cancer called multiple myeloma.
- The medicine has the name linvoseltamab.
- Doctors gave several treatment cycles to participants.
- Doctors used very sensitive bone marrow tests.
- The tests did not find cancer cells afterward.
- Some patients had low white blood cells.
- Serious immune reactions did not occur.
- Results are early but appear promising.
- The team will continue testing this treatment.
Difficult words
- antibody — A protein the immune system uses to fight germs
- multiple myeloma — A blood cancer that starts in bone marrow
- bone marrow — Soft tissue inside bones that makes blood cells
- white blood cell — A blood cell that helps fight infection and diseasewhite blood cells
- promising — Showing signs of future success or good results
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you try a new medicine in a medical test?
- Have you ever had a blood test?
- How do you feel if a test shows no cancer?
Related articles
25 Nov 2025
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.
25 Nov 2025
21 Jan 2026
5 Dec 2024
31 Jul 2025